4/13
04:05 pm
bbot
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Low
Report
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3/18
04:05 pm
bbot
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Low
Report
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
3/6
10:07 am
bbot
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
Low
Report
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
3/6
08:03 am
bbot
BridgeBio Oncology Therapeutics (BBOT) had its price target raised by HC Wainwright from $27.00 to $29.00. They now have a "buy" rating on the stock.
Low
Report
BridgeBio Oncology Therapeutics (BBOT) had its price target raised by HC Wainwright from $27.00 to $29.00. They now have a "buy" rating on the stock.
3/5
04:05 pm
bbot
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Medium
Report
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2/12
04:05 pm
bbot
BBOT to Participate in Upcoming Investor Healthcare Conferences
Low
Report
BBOT to Participate in Upcoming Investor Healthcare Conferences
2/11
04:05 pm
bbot
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2/10
06:05 pm
bbot
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) was given a new $23.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) was given a new $23.00 price target on by analysts at Stifel Nicolaus.
1/27
02:07 pm
bbot
Biotech investor Cormorant secures $150M for another SPAC deal [Yahoo! Finance]
Low
Report
Biotech investor Cormorant secures $150M for another SPAC deal [Yahoo! Finance]
1/23
08:44 am
bbot
Helix Acquisition prices $150M initial public offering [Seeking Alpha]
High
Report
Helix Acquisition prices $150M initial public offering [Seeking Alpha]